GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) » Definitions » Days Sales Outstanding

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Days Sales Outstanding : 0.00 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Sichuan Kelun-Biotech Biopharmaceutical Co Days Sales Outstanding?

Sichuan Kelun-Biotech Biopharmaceutical Co's average Accounts Receivable for the three months ended in Dec. 2023 was HK$0.0 Mil. Sichuan Kelun-Biotech Biopharmaceutical Co's Revenue for the three months ended in Dec. 2023 was HK$0.0 Mil.

The historical rank and industry rank for Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

HKSE:06990' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.07   Med: 0.86   Max: 1.65
Current: 0.17

During the past 3 years, Sichuan Kelun-Biotech Biopharmaceutical Co's highest Days Sales Outstanding was 1.65. The lowest was 0.07. And the median was 0.86.

HKSE:06990's Days Sales Outstanding is ranked better than
99.78% of 893 companies
in the Biotechnology industry
Industry Median: 72.43 vs HKSE:06990: 0.17

Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding stayed the same from Jun. 2022 (0.00) to Dec. 2023 (0.00).


Sichuan Kelun-Biotech Biopharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun-Biotech Biopharmaceutical Co Days Sales Outstanding Chart

Sichuan Kelun-Biotech Biopharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23
Days Sales Outstanding
1.65 0.07 -

Sichuan Kelun-Biotech Biopharmaceutical Co Quarterly Data
Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial - 0.14 0.22 - -

Competitive Comparison of Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding

For the Biotechnology subindustry, Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding falls into.



Sichuan Kelun-Biotech Biopharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 1684.959*365
=0 / 1684.959*365
=0.00

Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.001 + 0) / 1 ) / 0*365 / 4
=0.001 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Kelun-Biotech Biopharmaceutical Co  (HKSE:06990) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Sichuan Kelun-Biotech Biopharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Business Description

Traded in Other Exchanges
N/A
Address
No. 666 Xinhua Avenue, Chengdu Cross-Strait Science and Technology Industry Development Park, Wenjiang, Sichuan, Chengdu, CHN
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Headlines

No Headlines